390 related articles for article (PubMed ID: 16377775)
1. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.
Marteau P; Lémann M; Seksik P; Laharie D; Colombel JF; Bouhnik Y; Cadiot G; Soulé JC; Bourreille A; Metman E; Lerebours E; Carbonnel F; Dupas JL; Veyrac M; Coffin B; Moreau J; Abitbol V; Blum-Sperisen S; Mary JY
Gut; 2006 Jun; 55(6):842-7. PubMed ID: 16377775
[TBL] [Abstract][Full Text] [Related]
2. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection.
Van Gossum A; Dewit O; Louis E; de Hertogh G; Baert F; Fontaine F; DeVos M; Enslen M; Paintin M; Franchimont D
Inflamm Bowel Dis; 2007 Feb; 13(2):135-42. PubMed ID: 17206696
[TBL] [Abstract][Full Text] [Related]
3. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR;
Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
[TBL] [Abstract][Full Text] [Related]
4. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.
Fedorak RN; Feagan BG; Hotte N; Leddin D; Dieleman LA; Petrunia DM; Enns R; Bitton A; Chiba N; Paré P; Rostom A; Marshall J; Depew W; Bernstein CN; Panaccione R; Aumais G; Steinhart AH; Cockeram A; Bailey RJ; Gionchetti P; Wong C; Madsen K
Clin Gastroenterol Hepatol; 2015 May; 13(5):928-35.e2. PubMed ID: 25460016
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children.
Gotteland M; Andrews M; Toledo M; Muñoz L; Caceres P; Anziani A; Wittig E; Speisky H; Salazar G
Nutrition; 2008 May; 24(5):421-6. PubMed ID: 18343637
[TBL] [Abstract][Full Text] [Related]
6. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.
Prantera C; Scribano ML; Falasco G; Andreoli A; Luzi C
Gut; 2002 Sep; 51(3):405-9. PubMed ID: 12171964
[TBL] [Abstract][Full Text] [Related]
7. Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UV exposure-double blind, randomized, placebo controlled clinical trial.
Peguet-Navarro J; Dezutter-Dambuyant C; Buetler T; Leclaire J; Smola H; Blum S; Bastien P; Breton L; Gueniche A
Eur J Dermatol; 2008; 18(5):504-11. PubMed ID: 18693151
[TBL] [Abstract][Full Text] [Related]
8. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
[TBL] [Abstract][Full Text] [Related]
9. Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn's disease.
Klein O; Colombel JF; Lescut D; Gambiez L; Desreumaux P; Quandalle P; Cortot A
Am J Gastroenterol; 1995 Nov; 90(11):1949-52. PubMed ID: 7484997
[TBL] [Abstract][Full Text] [Related]
10. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Florent C; Cortot A; Quandale P; Sahmound T; Modigliani R; Sarfaty E; Valleur P; Dupas JL; Daurat M; Faucheron JL; Lerebours E; Michot F; Belaiche J; Jacquet N; Soulé JC; Rothman N; Gendre JP; Malafosse M
Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):229-33. PubMed ID: 8724022
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation.
Kopp MV; Hennemuth I; Heinzmann A; Urbanek R
Pediatrics; 2008 Apr; 121(4):e850-6. PubMed ID: 18332075
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: the effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease.
Shen J; Ran HZ; Yin MH; Zhou TX; Xiao DS
Intern Med J; 2009 Feb; 39(2):103-9. PubMed ID: 19220543
[TBL] [Abstract][Full Text] [Related]
13. Effects of probiotics on atopic dermatitis: a randomised controlled trial.
Weston S; Halbert A; Richmond P; Prescott SL
Arch Dis Child; 2005 Sep; 90(9):892-7. PubMed ID: 15863468
[TBL] [Abstract][Full Text] [Related]
14. A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease.
Reinisch W; Hommes DW; Van Assche G; Colombel JF; Gendre JP; Oldenburg B; Teml A; Geboes K; Ding H; Zhang L; Tang M; Cheng M; van Deventer SJ; Rutgeerts P; Pearce T
Gut; 2006 Aug; 55(8):1138-44. PubMed ID: 16492717
[TBL] [Abstract][Full Text] [Related]
15. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: A prospective, non-randomized, parallel, controlled study.
Yamamoto T; Nakahigashi M; Umegae S; Kitagawa T; Matsumoto K
Aliment Pharmacol Ther; 2007 Jan; 25(1):67-72. PubMed ID: 17229221
[TBL] [Abstract][Full Text] [Related]
16. Crohn's disease management after intestinal resection: a randomised trial.
De Cruz P; Kamm MA; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Gibson PR; Sparrow M; Leong RW; Florin TH; Gearry RB; Radford-Smith G; Macrae FA; Debinski H; Selby W; Kronborg I; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV
Lancet; 2015 Apr; 385(9976):1406-17. PubMed ID: 25542620
[TBL] [Abstract][Full Text] [Related]
17. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus GG in inducing and maintaining remission of Crohn's disease.
Schultz M; Timmer A; Herfarth HH; Sartor RB; Vanderhoof JA; Rath HC
BMC Gastroenterol; 2004 Mar; 4():5. PubMed ID: 15113451
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study.
Hatakka K; Blomgren K; Pohjavuori S; Kaijalainen T; Poussa T; Leinonen M; Korpela R; Pitkäranta A
Clin Nutr; 2007 Jun; 26(3):314-21. PubMed ID: 17353072
[TBL] [Abstract][Full Text] [Related]
20. Oral treatment with probiotic Lactobacillus johnsonii NCC533 (La1) for a specific part of the weaning period prevents the development of atopic dermatitis induced after maturation in model mice, NC/Nga.
Inoue R; Nishio A; Fukushima Y; Ushida K
Br J Dermatol; 2007 Mar; 156(3):499-509. PubMed ID: 17300240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
